About this trial
Heart failure is under-diagnosed, even though it is a highly prevalent pathology. The difficulties are accentuated in areas with low medical density. The aim of this project is to demonstrate the value, in terms of diagnosing heart failure, of a Nt-Pro-BNP point of care Test (POCT)in general practices. The aim of this pilot study is to evaluate the reliability of a diagnosis pathway adapted to a low medical density region.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients over 60 years of age
Patient presenting at least 1 sign of EPOF on clinical examination (Shortness of breath at rest or on exertion, orthopnea, nocturnal cough; Rapid weight gain, hepatomegaly ; Peripheral edema ; Fatigue (asthenia), difficulty performing daily activities)
Disqualifiers
Patients covered by Articles L1121-5 through L1121-8 of the Public Health Code (persons under legal protection, guardianship, or conservatorship)
Patients not enrolled in the French social security system or an equivalent program
Lack of free and informed consent
Trial design
Parallel
Treatments tested in this trial
Point-of-care NT-pro-BNP testing
Diagnostic testCapillary NT-pro-BNP testing performed in primary care settings using a point-of-care platform to support early diagnosis of heart failure in rural territories.
Treatment groups
Trial outcomes
Primary outcomes
Changes in the estimated Annual Incidence of Heart Failure in the geographical area of intervention
The primary outcome is changes in the estimated annual incidence of heart failure in the geographical area of intervention using data from French National Health Data System (SNDS). Incidental cases are defined as subject with first dispensing of at least one of the following : * Sacubitril/valsartan and/or * Spironolactone/eplerenone and/or * Glifozine
Secondary outcomes
Number of Patients whose diagnosis of CI is ruled out (rule-out),
Number of patients for whom the diagnosis of heart failure is ruled out (rule-out strategy)
Number of Hospitalizations or Cardiovascular Events at 1 Year among patients in the experimental group.
Number of hospitalizations or cardiovascular events occurring within 1 year in the geographical area of the intervention
Number of Patient with Heart Failure Classified According to Ejection Fraction After Cardiology Consultation - Preserved ejection fraction (EF)
Number of patients classified as having preserved EF after cardiology consultation.
Number of Patient with Heart Failure Classified According to Ejection Fraction After Cardiology Consultation - Moderately impaired ejection fraction (EF)
Number of patients classified as having moderately impaired EF after cardiology consultation.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: